These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Discontinuation of alprazolam treatment in panic patients. Fyer AJ; Liebowitz MR; Gorman JM; Campeas R; Levin A; Davies SO; Goetz D; Klein DF Am J Psychiatry; 1987 Mar; 144(3):303-8. PubMed ID: 3826428 [TBL] [Abstract][Full Text] [Related]
6. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam. Swinson RP; Pecknold JC; Kuch K Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):105-13. PubMed ID: 3628823 [TBL] [Abstract][Full Text] [Related]
8. Clonazepam in the treatment of patients with recurrent panic attacks. Beaudry P; Fontaine R; Chouinard G; Annable L J Clin Psychiatry; 1986 Feb; 47(2):83-5. PubMed ID: 3944069 [TBL] [Abstract][Full Text] [Related]
9. Successful use of clonazepam in patients with treatment-resistant panic disorder. Tesar GE; Rosenbaum JF J Nerv Ment Dis; 1986 Aug; 174(8):477-82. PubMed ID: 3734770 [TBL] [Abstract][Full Text] [Related]
10. The realities of clonazepam discontinuation. Freeman S Psychiatr Serv; 1997 Jul; 48(7):881-2. PubMed ID: 9219294 [No Abstract] [Full Text] [Related]
11. Alprazolam treatment for panic disorder. Miller F J Clin Psychiatry; 1987 Jul; 48(7):301. PubMed ID: 3597336 [No Abstract] [Full Text] [Related]
12. Continuation treatment of panic disorder with high-potency benzodiazepines. Davidson JR J Clin Psychiatry; 1990 Dec; 51 Suppl A():31-7. PubMed ID: 2258375 [TBL] [Abstract][Full Text] [Related]
13. The relationship of alprazolam dose to steady-state plasma concentrations. Ciraulo DA; Antal EJ; Smith RB; Olson DR; Goldberg DA; Rand EH; Raskin RB; Phillips JP; Shader RI; Greenblatt DJ J Clin Psychopharmacol; 1990 Feb; 10(1):27-32. PubMed ID: 2407754 [TBL] [Abstract][Full Text] [Related]
14. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects. Pecknold JC; Swinson RP; Kuch K; Lewis CP Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479 [TBL] [Abstract][Full Text] [Related]
15. Alprazolam in panic disorder: a retrospective analysis. Shelton RC; Harvey DS; Stewart PM; Loosen PT Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):423-34. PubMed ID: 8475324 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of benzodiazepines in panic disorder and agoraphobia. Ballenger JC J Psychiatr Res; 1990; 24 Suppl 2():15-25. PubMed ID: 1980694 [TBL] [Abstract][Full Text] [Related]
17. The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports. Marks IM; De Albuquerque A; Cottraux J; Gentil V; Greist J; Hand I; Liberman RL; Relvas JS; TobeƱa A; Tyrer P Arch Gen Psychiatry; 1989 Jul; 46(7):668-72. PubMed ID: 2660772 [No Abstract] [Full Text] [Related]
18. Treatment of panic disorder and benzodiazepine withdrawal with valproate. McElroy SL; Keck PE; Lawrence JM J Neuropsychiatry Clin Neurosci; 1991; 3(2):232-3. PubMed ID: 1821239 [No Abstract] [Full Text] [Related]
19. Drug treatment of panic disorder. Reply to comment by Marks and associates. Klerman GL Br J Psychiatry; 1992 Oct; 161():465-71. PubMed ID: 1309180 [No Abstract] [Full Text] [Related]
20. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. Noyes R; DuPont RL; Pecknold JC; Rifkin A; Rubin RT; Swinson RP; Ballenger JC; Burrows GD Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]